ProQR Therapeutics N.V. announced key leadership appointments, naming Dennis Hom as Chief Financial Officer (CFO) and Dr. Cristina Lopez Lopez as Chief Medical Officer (CMO). These appointments are intended to support the advancement of the company’s Axiomer platform and pipeline as it enters the clinical stage.
Dennis Hom brings over 25 years of financial leadership, having previously served as CFO at Sagimet Biosciences, where he raised over $4.5 billion in capital and executed transactions exceeding $57 billion. He will oversee corporate finance, investor relations, and business development at ProQR.
Dr. Cristina Lopez Lopez, with over 20 years of global leadership in translational R&D, was most recently Global Head of Neurodegeneration at Johnson & Johnson. She will lead all preclinical, translational, clinical, and regulatory activities for ProQR, while former CFO Jurriaan Dekkers and Chief Corporate Development Officer René Beukema will transition out of their roles.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.